Preliminary antimicrobial susceptibility interpretive criteria for cefetamet (Ro 15-8074) and cefteram (Ro 19-5247) disk tests.
about
Predictive accuracy of disk diffusion test for Proteus vulgaris and Providencia species against five newer orally administered cephalosporins, cefdinir, cefetamet, cefprozil, cefuroxime, and loracarbefPreliminary disk diffusion susceptibility testing criteria for cefdaloxime (RU29246, HR-916 metabolite), a new orally administered cephalosporin.Antimicrobial activity and disk diffusion susceptibility testing of U-76,253A (R-3746), the active metabolite of the new cephalosporin ester, U-76,252 (CS-807)Antimicrobial activity, spectrum, and recommendations for disk diffusion susceptibility testing of ceftibuten (7432-S; SCH 39720), a new orally administered cephalosporin.Use of a predictor panel for development of a new disk for diffusion tests with cefoperazone-sulbactam.MIC quality control guidelines for Haemophilus susceptibility tests using cefdinir (FK482), cefepime, cefetamet, cefpirome, ceftibuten, fleroxacin, temafloxacin, clarithromycin, RP59500, and trospectomycin.Interpretive criteria for disk diffusion tests using 5-microgram cefdinir disks with rapidly growing clinical isolatesMIC and disk diffusion quality control guidelines for Neisseria gonorrhoeae susceptibility tests of cefdinir, cefetamet, CI-960, fleroxacin, lomefloxacin, and temafloxacinInterpretive accuracy of the disk diffusion method for testing newer orally administered cephalosporins against Morganella morganii.Disk diffusion susceptibility testing for LY163892 (KT-3777), a new orally administered 1-carbacephemDisk diffusion susceptibility testing and broth microdilution quality control guidelines for BMY-28100, a new orally administered cephalosporin
P2860
Q24645422-2102CBCC-5364-4456-ABE8-B5D6BA29FAADQ33214058-7464C2C3-6D59-43C9-90C5-17EBB8207A9BQ35297977-6D0EF057-F449-4CF9-8205-CE006E657D57Q35564509-D333221A-47B6-41DE-BC52-BAC14805FF8EQ35826023-7A0FD74D-18E5-4DB7-948B-7AFE921F3617Q37115080-76823AB9-06D2-44BC-B2B2-5B62146CEE97Q37119382-9A110E8F-5916-43A2-A8FF-0AC7C457C91DQ37120847-9C5B41A4-6EB0-4B76-A928-78D943E13290Q37139121-F3BBD3B1-8043-47DB-AC24-D5EC861066B6Q37148006-B7D6CD89-0EC0-4B60-92FE-7C08646B1689Q37222684-8F24CF51-F35B-4B2D-82E9-D18F04D2D00F
P2860
Preliminary antimicrobial susceptibility interpretive criteria for cefetamet (Ro 15-8074) and cefteram (Ro 19-5247) disk tests.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on September 1987
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Preliminary antimicrobial susc ...... teram (Ro 19-5247) disk tests.
@en
Preliminary antimicrobial susceptibility interpretive criteria for cefetamet
@nl
type
label
Preliminary antimicrobial susc ...... teram (Ro 19-5247) disk tests.
@en
Preliminary antimicrobial susceptibility interpretive criteria for cefetamet
@nl
prefLabel
Preliminary antimicrobial susc ...... teram (Ro 19-5247) disk tests.
@en
Preliminary antimicrobial susceptibility interpretive criteria for cefetamet
@nl
P2860
P1476
Preliminary antimicrobial susc ...... teram (Ro 19-5247) disk tests.
@en
P2093
P2860
P304
P407
P577
1987-09-01T00:00:00Z